Empowering Longevity Science with Nucleotide Innovation
Dalian Zhen-Ao Bio-Tech Contributes 5′-Nucleotides to the TALENTs Clinical Study
Zhen-Ao Group has recently achieved a significant scientific milestone in the field of healthy aging through the internationally recognized TALENTs Study, a multi-center, randomized, double-blind, placebo-controlled clinical trial conducted in collaboration with leading academic institutions including Peking University.
As a core subsidiary of the Group, Dalian Zhen-Ao Bio-Tech Co., Ltd. proudly supplied its proprietary 5′-Nucleotide ingredients, produced through advanced enzymatic extraction and precision fermentation technologies. These bioactive compounds played a crucial role in supporting the study’s exploration of nucleotides as a novel nutritional intervention to improve cellular function, cognition, and vitality in aging populations.
The positive results from the TALENTs Study provide strong scientific evidence for the potential of nucleotides as an emerging category in anti-aging nutrition, further validating Zhen-Ao’s long-standing commitment to biotechnology innovation and evidence-based health solutions.
Zhen-Ao Bio-Tech will continue to advance its research partnerships and product innovation to unlock the broader applications of nucleotides and yeast-derived bioactives in human health, nutrition, and longevity science.
About Dalian Zhen-Ao Bio-Tech Co., Ltd.
A subsidiary of Zhen-Ao Group, Dalian Zhen-Ao Bio-Tech specializes in the research and production of Ribonucleic Acid (RNA), 5′-Nucleotides, Yeast Extracts, and Functional Yeast Proteins. With globally leading fermentation and extraction platforms, the company serves partners across the food, nutrition, pharmaceutical, and health industries with high-quality, science-backed ingredients that support natural health and flavor.
